Altre lingue Covalon Technologies Ltd.

Azioni

COV

CA22282D3022

Mercato chiuso - Toronto S.E. Altri mercati azionari 21:44:38 24/05/2024			Variaz. 5gg	Var. 1 gen.
1,09 ^CAD	-0,91%		0,00%	+2,83%

06/03	Transcript : Covalon Technologies Ltd. - Shareholder/Analyst Call
28/02	Covalon Technologies Ltd. riporta i risultati degli utili per il primo trimestre conclusosi il 31 dicembre 2023	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Covalon Announces Conference Call to Discuss Second Quarter Fiscal 2024 Financial Results	23/05
Covalon Technologies Presents Compassionate Care Technology at the Infusion Nurses Society Annual Meeting and Exhibition in Kansas City, MO	20/05
Covalon Presents Compassionate Care Technology at the Infusion Nurses Society (INS) Annual Meeting & Exhibition in Kansas City, MO	17/05
Covalon Announces Voting Results from Fiscal 2023 Annual Meeting of Shareholders	08/03
Covalon Technologies : FY2023 AGM Management Presentation	06/03
Covalon to Hold Annual Meeting of Shareholders on Wednesday, March 6, 2024	29/02
Covalon Technologies Ltd. Reports Earnings Results for the First Quarter Ended December 31, 2023	28/02
Covalon Announces First Quarter Fiscal 2024 Results	28/02
Covalon Announces Fourth Quarter and Year End Results for Fiscal 2023	29/01
Covalon Announces Management Changes	29/01
Covalon Technologies Reports Management Changes; Narrows Fiscal Q4 Loss, Revenue Grows; Up 17.8%	26/01
Covalon Technologies Reports Management Changes; Narrows Fiscal Q4 Loss, Revenue Grows	26/01
Covalon Technologies Narrows Fiscal Q4 Loss, Revenue Grows	26/01
Covalon Technologies Ltd. Announces Interim Chief Financial Officer Changes	26/01
Covalon Technologies Ltd. Announces Appointment of Kim Crooks as Senior Vice President - Operations	26/01
Covalon Technologies Brief: Reporting 2023-Q4 revenue of $6.9 million, an increase of 28%, and net loss from continuing operations of $2.9 million, an improvement of $1.2 million	26/01
Covalon Technologies Ltd. Reports Earnings Results for the Full Year Ended September 30, 2023	26/01
Covalon Technologies Ltd. Reports Earnings Results for the Fourth Quarter Ended September 30, 2023	26/01
Covalon Technologies Ltd. Announces the Appointment of Experienced MedTech Executive Mr. Brent Ashton as New CEO	05/01
Covalon Technologies Ltd. Announces Chief Executive Officer Changes	04/01

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Covalon Technologies Ltd.

Azioni

COV

CA22282D3022

Altre lingue

Filtri